Despite recent evidence implicating the nucleus accumbens (NAc) as causally involved in the transition to chronic pain in humans, underlying mechanisms of this involvement remain entirely unknown. Here we elucidate mechanisms of NAc reorganizational properties (longitudinally and cross-sectionally), in an animal model of neuropathic pain (spared nerve injury [SNI]). We observed interrelated changes: (1) In resting-state functional magnetic resonance imaging (fMRI), functional connectivity of the NAc to dorsal striatum and cortex was reduced 28 days (but not 5 days) after SNI; (2) Contralateral to SNI injury, gene expression of NAc dopamine 1A, 2, and j-opioid receptors decreased 28 days after SNI; (3) In SNI (but not sham), covariance of gene expression was upregulated at 5 days and settled to a new state at 28 days; and (4) NAc functional connectivity correlated with dopamine receptor gene expression and with tactile allodynia. Moreover, interruption of NAc activity (via lidocaine infusion) reversibly alleviated neuropathic pain in SNI animals. Together, these results demonstrate macroscopic (fMRI) and molecular reorganization of NAc and indicate that NAc neuronal activity is necessary for full expression of neuropathic painlike behavior.
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Introduction
Concepts regarding the role of nucleus accumbens (NAc) in pain, and in chronification of pain, are undergoing rapid advances. Until recently, this nucleus was thought to be primarily involved in evaluating reward signals, yet new evidence shows that it also encodes salience for pain, and value for pain relief and that NAc valuation of acute analgesia is distorted in chronic pain patients [9, 12, 13, 54, 64, 65] . Recent evidence indicates that increased functional connectivity between NAc and the prefrontal cortex is predictive of the transition from acute to chronic pain 1 year prior to pain chronification [10] . Despite these advances, the mechanistic implications of the macroscopic human brain imaging-based findings remain unknown, even though they were predicated on the hypothesis that NAc dopaminergic learning mechanisms may play an essential role in pain chronification [7] .
The NAc is a central component of the mesocorticolimbic system [5, 19, 31] ; a brain network closely associated with emotional learning, motivated and addictive behavior, in which dopaminergic neurotransmission and modulation are thought to supply the critical learning signal. Knowledge of the role of the mesolimbic circuitry in pain is increasing. The association between mesolimbic circuitry and neural substrates of pain and analgesia has been considered in past decades [29, 37, 53] ; for noxious or aversive conditions, both excitatory and inhibitory responses of dopaminergic neurons have been observed [16, 23, 43, 50, 62, 68] , both increases and decreases in extracellular dopamine are reported [11, 51] , and corresponding results are found in human studies [44, 46] . Moreover, in patients with central disorders such as schizophrenia, Parkinson's disease, substance abuse, and mood and anxiety disorders, pain sensitivity is altered, presumably as a consequence of changes in the dopaminergic system [1, 42, 71] , and animal studies implicate dopamine in acute and neuropathic conditions [6, 26, 60] . 
